These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26782462)

  • 21. Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival.
    Guo L; Zheng J; Yu T; Liu Y; Duo L
    Mol Med Rep; 2017 Dec; 16(6):8842-8848. PubMed ID: 28990092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 overexpression related to lymph node metastasis and poor prognosis of pancreatic cancer.
    Liu Y; Wu T; Lu D; Zhen J; Zhang L
    Int J Biol Markers; 2018 Aug; 33(3):308-313. PubMed ID: 29683068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of microRNA-20b expression level in patients with prostate cancer.
    Zhang R; Li F; Wang Y; Yao M; Chi C
    Histol Histopathol; 2020 Aug; 35(8):827-831. PubMed ID: 32286677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukemia inhibitory factor is a novel biomarker to predict lymph node and distant metastasis in pancreatic cancer.
    Jiang W; Bai W; Li J; Liu J; Zhao K; Ren L
    Int J Cancer; 2021 Feb; 148(4):1006-1013. PubMed ID: 32914874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlated high expression of FXR and Sp1 in cancer cells confers a poor prognosis for pancreatic cancer: A study based on TCGA and tissue microarray.
    Hu H; Wu LL; Han T; Zhuo M; Lei W; Cui JJ; Jiao F; Wang LW
    Oncotarget; 2017 May; 8(20):33265-33275. PubMed ID: 28402278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between miR-1178 expression and clinicopathological significance in human pancreatic cancer].
    Cao Z; Zheng SL; Yang G; Feng MY; Zheng LF; Zhang TP; Zhao YP
    Zhonghua Wai Ke Za Zhi; 2017 Jun; 55(6):468-473. PubMed ID: 28592083
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance and prognostic value of SOX7 expression in liver and pancreatic carcinoma.
    Wang J; Zhang S; Wu J; Lu Z; Yang J; Wu H; Chen H; Lin B; Cao T
    Mol Med Rep; 2017 Jul; 16(1):499-506. PubMed ID: 28586005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.
    Liu C; Fu X; Zhong Z; Zhang J; Mou H; Wu Q; Sheng T; Huang B; Zou Y
    Dig Dis Sci; 2017 Sep; 62(9):2376-2385. PubMed ID: 28646284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Up-regulated expression of miR-155 in human colonic cancer.
    Cao H; Huang S; Liu A; Chen Z
    J Cancer Res Ther; 2018; 14(3):604-607. PubMed ID: 29893326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of stromal caveolin-1 expression: a novel tumor microenvironment biomarker that can predict poor clinical outcomes for pancreatic cancer.
    Shan T; Lu H; Ji H; Li Y; Guo J; Chen X; Wu T
    PLoS One; 2014; 9(6):e97239. PubMed ID: 24949874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma.
    Wang D; Liu K; Yang Y; Wang T; Rao Q; Guo W; Zhang Z
    Future Oncol; 2020 Jan; 16(3):4461-4473. PubMed ID: 31854204
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer.
    Yu H; Song H; Ma Z; Ji W
    Open Life Sci; 2018 Jan; 13():497-503. PubMed ID: 33817119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular mechanism underlying lymphatic metastasis in pancreatic cancer.
    Xiao Z; Luo G; Liu C; Wu C; Liu L; Liu Z; Ni Q; Long J; Yu X
    Biomed Res Int; 2014; 2014():925845. PubMed ID: 24587996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor innervation and clinical outcome in pancreatic cancer.
    Ferdoushi A; Griffin N; Marsland M; Xu X; Faulkner S; Gao F; Liu H; King SJ; Denham JW; van Helden DF; Jobling P; Jiang CC; Hondermarck H
    Sci Rep; 2021 Apr; 11(1):7390. PubMed ID: 33795769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression and prognostic significance of
    Xie D; Yuan P; Wang D; Jin H; Chen H
    Oncol Lett; 2017 Aug; 14(2):2305-2309. PubMed ID: 28781668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer - A systematic review and meta-analysis.
    Negoi I; Hostiuc S; Sartelli M; Negoi RI; Beuran M
    Am J Surg; 2017 Sep; 214(3):515-524. PubMed ID: 28477839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of folate receptor alpha is an independent prognostic factor for outcomes of pancreatic cancer patients.
    Omote S; Takata K; Tanaka T; Miyata-Takata T; Ayada Y; Noujima-Harada M; Omote R; Tabata T; Sato Y; Toyokawa T; Kato H; Yagi T; Okada H; Yoshino T
    Med Mol Morphol; 2018 Dec; 51(4):237-243. PubMed ID: 29926190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of miR-21 and miR-138 in colon cancer and its effect on cell proliferation and prognosis.
    You C; Jin L; Xu Q; Shen B; Jiao X; Huang X
    Oncol Lett; 2019 Feb; 17(2):2271-2277. PubMed ID: 30675293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer.
    Sui L; Ye L; Sanders AJ; Yang Y; Hao C; Hargest R; Jiang WG
    Anticancer Res; 2021 May; 41(5):2357-2362. PubMed ID: 33952460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of CA 19.9 and LINC01197 in pancreatic cancer.
    Jia YH; Zheng WW; Ye ZH
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2358-2367. PubMed ID: 32196587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.